ARS Pharmaceuticals, Inc. logo SPRY - ARS Pharmaceuticals, Inc.

Price: -- -- | CONSENSUS: Hold DETAILS
STRONG
BUY
1
BUY 3
HOLD 6
SELL 0
STRONG
SELL
0
| PRICE TARGET: $20.00 DETAILS
HIGH: $25.00
LOW: $15.00
MEDIAN: $20.00
CONSENSUS: $20.00
UPSIDE: 276.22%
Metric 2026 Q2 2026 Q1 2025 Q4 2025 Q3 2025 Q2 2025 Q1 2024 Q4 2024 Q3 2024 Q2 2024 Q1 2023 Q4 2023 Q3 2023 Q2 2023 Q1 2022 Q4 2022 Q3 2022 Q2 2022 Q1 2021 Q4 2021 Q3 2021 Q2 2021 Q1 2020 Q4 2020 Q2 2020 Q1 2019 Q4
Revenue
Revenue 33.7 22.7 28.1 32.5 15.7 8.0 86.6 2.1 0.5 0 0 0 0.0 0.0 0 0.2 0.5 0.7 0.8 0.5 2.1 2.1 0 0 0 0
Cost of Revenue 12.8 6.3 3.2 8.2 5.0 4.0 3.9 0.1 6.9 5.2 3.4 3.0 7.2 6.5 3.6 3.8 4.3 5.4 3.9 5.1 5.6 5.6 0.5 0.4 0.4 0.4
Gross Profit 20.8 16.4 24.9 24.3 10.7 3.9 82.7 2.0 (6.4) (5.2) (3.4) (3.0) (7.2) (6.4) (3.6) (3.6) (3.9) (4.8) (3.2) (4.6) (3.5) (3.5) (0.5) (0.4) (0.4) (0.4)
Operating Expenses
R&D Expenses 4.7 4.3 3.4 2.8 4.0 3.0 3.0 4.4 6.9 5.2 3.4 3.0 7.3 6.6 4.7 3.9 4.3 5.4 3.9 5.1 5.6 5.6 8.6 5.0 4.3 6.3
SG&A Expenses 77.6 72.2 60.0 74.8 54.3 0 0 19.3 8.9 0 0 0 13.4 12.3 10.8 3.0 2.5 2.3 1.8 1.0 0.9 0.9 4.0 1.1 0.6 0.3
Other Expenses 0 0 3.0 0 0 38.2 32.5 0 (6.9) 2.7 3.4 12.0 (7.3) (6.6) (3.7) (3.9) (4.3) (5.4) (3.9) (5.1) (5.6) (5.6) 0 0 0 0
Operating Expenses 82.3 76.5 66.3 77.5 58.3 41.1 35.5 23.7 8.9 8.0 6.8 15.0 13.4 12.3 11.9 3.0 2.5 2.3 1.8 1.0 0.9 0.9 12.6 6.1 4.8 6.5
Operating Income
Operating Income (61.5) (60.1) (41.5) (53.2) (47.6) (37.2) 47.2 (21.7) (15.3) (13.2) (10.2) (18.0) (20.6) (18.7) (15.4) (6.6) (6.3) (7.1) (5.0) (5.6) (4.4) (4.4) (13.1) (6.5) (5.2) (6.9)
Interest Expense 2.5 2.4 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.0 0.0 0.0
Interest Income 1.6 2.0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.0 0 0 0 0.0 0 0 0
Profitability
EBITDA (59.4) (57.8) (41.0) (48.8) (44.6) (33.7) 50.3 (19.1) (12.5) (10.3) (7.2) (14.8) (17.4) (14.9) (14.2) (6.6) (6.4) (7.2) (4.9) (5.8) (4.6) (4.4) (12.6) (6.1) (4.8) (6.5)
EBIT (59.9) (58.2) (41.4) (51.2) (44.9) (33.9) 50.2 (19.1) (12.5) (10.3) (7.2) (14.9) (17.4) (15.0) (14.4) (6.6) (6.4) (7.2) (5.1) (5.8) (4.6) (4.4) (13.1) (6.5) (5.2) (6.9)
Income Before Tax (62.3) (60.6) (41.4) (51.2) (44.9) (33.9) 50.2 (19.1) (12.5) (10.3) (7.2) (14.9) (17.4) (15.0) (14.4) (6.6) (6.4) (7.2) (5.1) (5.8) (4.6) (4.6) (13.1) (6.5) (5.3) (7.0)
Income Tax Expense 0 0 (0.1) 0 0 0 0.3 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Net Income (62.3) (60.6) (41.3) (51.2) (44.9) (33.9) 49.9 (19.1) (12.5) (10.3) (7.2) (14.9) (17.4) (15.0) (14.4) (6.6) (6.4) (7.2) (5.1) (5.8) (4.6) (4.6) (13.1) (6.5) (5.3) (7.0)
Per Share Data
EPS (Basic) -0.63 -0.61 -0.42 -0.52 -0.46 -0.35 0.51 -0.20 -0.13 -0.11 -0.07 -0.16 -0.18 -0.16 -0.15 -0.07 -0.07 -0.08 -0.15 -0.17 -0.13 -0.13 -0.38 -0.19 -0.16 -0.21
EPS (Diluted) -0.63 -0.61 -0.42 -0.52 -0.46 -0.35 0.51 -0.20 -0.13 -0.11 -0.07 -0.16 -0.18 -0.16 -0.15 -0.07 -0.07 -0.08 -0.15 -0.17 -0.13 -0.13 -0.38 -0.19 -0.16 -0.21
Shares Outstanding 99.3 99.3 98.6 98.8 98.4 98.1 98.0 97.0 96.8 96.5 96.1 95.6 94.9 94.2 94.0 93.8 93.8 93.8 35.0 35.0 34.9 34.8 34.7 34.8 33.1 33.1
Metric 2026 Q2 2026 Q1 2025 Q4 2025 Q3 2025 Q2 2025 Q1 2024 Q4 2024 Q3 2024 Q2 2024 Q1 2023 Q4 2023 Q3 2023 Q2 2023 Q1 2022 Q4 2022 Q3 2022 Q2 2022 Q1 2021 Q4 2021 Q3 2021 Q2 2021 Q1 2020 Q4 2019 Q4
Current Assets
Cash & Cash Equivalents 8.2 24.3 41.3 59.6 51.5 39.9 50.8 39.7 36.6 56.0 71.0 60.5 119.0 87.9 210.5 37.3 44.6 234.0 60.1 300.7 359.7 374.2 386.6 10.0
Short-Term Investments 135.7 176.6 203.7 228.7 188.6 235.9 263.2 165.0 182.1 167.6 157.4 181.4 133.2 176.7 63.9 0 0 19.9 0 0 0 0 0 0
Net Receivables 46.8 29.5 26.3 37.7 26.1 10.3 9.2 1.2 0.5 0.6 0.8 0.8 1.0 0.5 0 0 0.0 0 0.0 0 0 0 0 0
Inventory 11.7 8.8 8.4 7.8 8.7 7.3 5.2 0.7 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Current Assets 0 6.0 5.2 1.3 2.0 1.0 1.2 0.6 0.3 0.3 0 0 0 0 1.0 1.2 0 7.5 0 4.7 3.3 4.1 4.1 0.6
Total Current Assets 211.5 245.2 284.9 338.9 281.4 303.9 334.3 208.8 220.7 226.2 231.6 244.5 255.0 267.4 277.7 39.1 45.4 261.3 60.7 305.4 363.0 378.3 390.7 10.5
Non-Current Assets
Property, Plant & Equipment 2.1 2.3 2.5 2.6 2.6 1.1 1.1 0.9 0.8 0.8 0.8 0.9 0.9 1.0 0.8 0.6 0.6 6.9 0.7 6.9 3.6 3.5 3.8 4.6
Goodwill 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Intangible Assets 13.9 14.2 14.5 14.7 13.2 7.5 7.7 7.9 0.4 0.5 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Long-Term Investments 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 44.2 0 40.3 0.3 0.3 0.3 0.6
Other Non-Current Assets 22 25.9 25.8 16.6 16.2 14.8 8.1 0 0 0 0.8 3.2 2.8 2.9 3.0 0.0 0.0 0 0.0 (0.0) 0 0 0 0
Total Non-Current Assets 38.0 42.3 42.8 33.9 32.0 23.5 16.9 8.8 1.2 1.3 1.6 4.1 3.7 3.8 3.7 0.6 0.7 51.1 0.7 47.2 3.9 3.9 4.1 5.1
Total Assets 249.5 287.6 327.7 372.8 313.5 327.3 351.2 217.6 222.0 227.6 233.2 248.6 258.8 271.2 281.4 39.7 46.0 312.5 61.4 352.6 367.0 382.2 394.8 15.6
Current Liabilities
Account Payables 59.7 4.7 5.7 8.4 15.6 4.1 9.9 8.3 3.3 0.8 0.8 3.0 1.5 2.6 1.7 2.5 1.9 2.6 1.8 1.7 1.8 4.4 2.6 3.5
Short-Term Debt 0 0 0 0.6 0 0 0 0 0 0 0.2 0.2 0 0.2 0 3.5 3.5 1.1 3.5 1.1 1.0 1.4 1.7 12.3
Deferred Revenue 0.5 0.8 0.6 0 0.7 0.5 0.6 0 0 0 0 0 0 0.0 0 0 0.3 0 1.5 0 0 0 0 0
Other Current Liabilities 0.6 0.6 0.6 41.9 4.3 4.7 2.3 2.6 1.5 1.1 1.1 5.8 0.3 5.8 1.5 0.8 0.5 9.0 0.7 9.3 10.6 4.1 5.3 2.1
Total Current Liabilities 60.9 49.6 39.1 50.9 45.6 27.6 23.4 16.6 6.7 3.7 2.4 11.2 10.1 9.8 5.4 8.3 7.5 14.8 8.2 15.3 15.5 11.6 9.6 17.9
Non-Current Liabilities
Long-Term Debt 171.6 96.5 96.4 0.9 0 0 0 0 0 0 0 0 0 0 0 2.3 3.2 0 4.9 0 0 0 0 0
Deferred Tax Liabilities 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Non-Current Liabilities 3.4 79.2 76.7 173.3 73.4 69.4 69.4 0 0 0 0 0 0 0 2.9 2.9 76.1 0 76.1 0 0 0 0 0
Total Non-Current Liabilities 176.1 176.7 174.2 174.3 75.6 70.7 70.9 0 0 0 0.0 0.1 0.1 0.2 3.1 5.5 82.6 4.4 84.5 5.1 1.8 2.1 2.3 3.3
Total Liabilities 237.0 226.3 213.4 225.1 121.2 98.3 94.4 16.6 6.7 3.7 2.4 11.3 10.2 10.0 8.5 13.8 90.1 19.2 92.7 20.4 17.3 13.7 11.9 21.2
Stockholders' Equity
Common Stock 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0
Retained Earnings (417.6) (355.2) (294.6) (253.3) (202.1) (157.2) (123.3) (173.2) (154.1) (141.6) (131.3) (124.1) (109.3) (91.9) (76.9) (62.5) (55.9) (210.8) (42.3) (162.8) (140.1) (115.6) (96.7) (63.8)
Accumulated Other Comprehensive Income (0.1) (0.1) 0.1 (0.0) (0.0) 0.1 0.2 0.3 (0.1) (0.1) 0.0 (0.2) (0.2) 0.1 0.4 0 0 (1.2) 0 (0.0) 0 0 0 0
Total Stockholders' Equity 12.5 61.3 114.3 147.7 192.3 229.0 256.8 201.0 215.2 223.9 230.8 237.3 248.6 261.2 272.9 25.9 (44.0) 293.2 (31.3) 332.1 349.6 368.5 382.9 (5.6)
Total Liabilities & Equity 249.5 287.6 327.7 372.8 313.5 327.3 351.2 217.6 222.0 227.6 233.2 248.6 258.8 271.2 281.4 39.7 46.0 312.5 61.4 352.6 367.0 382.2 394.8 15.6
Debt Metrics
Total Debt 171.6 96.5 96.4 1.5 1.7 0.1 0.0 0.1 0.2 0.2 0.3 0.3 0.4 0.4 0.5 6.3 7.3 5.6 9.0 6.2 2.7 3.5 4.1 15.6
Net Debt 163.4 72.2 55.1 (58.0) (49.9) (39.8) (50.8) (39.6) (36.5) (55.8) (70.7) (60.2) (118.6) (87.4) (210.0) (31.0) (37.3) (228.4) (51.0) (294.5) (357.0) (370.7) (382.5) 5.6
Metric 2026 Q2 2026 Q1 2025 Q4 2025 Q3 2025 Q2 2025 Q1 2024 Q4 2024 Q3 2024 Q2 2024 Q1 2023 Q4 2023 Q3 2023 Q2 2023 Q1 2022 Q4 2022 Q3 2022 Q2 2022 Q1 2021 Q4 2021 Q3 2021 Q2 2021 Q1 2020 Q2 2020 Q1
Operating Activities
Net Income (62.3) (60.6) (41.3) (51.2) (44.9) (33.9) 49.9 (19.1) (12.5) (10.3) (7.2) (14.9) (17.4) (15.0) (14.4) (6.6) (6.4) (7.2) (23.5) (22.7) (24.5) (18.9) (6.5) (5.3)
Depreciation & Amortization 0.4 0.4 (1.5) 2.4 0.3 (1.7) (1.5) 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.4 0.5 0.5 0.5 0.4 0.4
Stock-Based Compensation 12.4 7.4 5.7 5.7 5.4 5.3 4.3 3.6 3.4 3.3 2.3 2.6 0 0 4.8 0.5 0 0.3 0 0 0 0 0 0
Change in Working Capital (12.8) 8.6 (7.5) (1.1) (1.1) (10.4) (10.7) (1.5) 3.8 2.2 (10.8) 1.0 0.3 2.1 (0.8) (0.3) (1.0) 0.0 (3.4) (2.0) 5.1 1.9 0.5 (2.8)
Other Non-Cash Items 1.4 (0.7) 1.1 (2.9) 0.7 0 0 2.5 (1.9) (2.0) 9.4 (1.6) 0.3 0.4 (10.1) 0.7 (0.1) (0.0) 5.2 5.0 4.7 4.3 0.1 0.1
Operating Cash Flow (60.9) (44.9) (43.5) (47.0) (39.6) (40.7) 42.0 (14.5) (7.3) (6.7) (17.4) (12.8) (16.7) (12.4) (20.5) (5.7) (7.0) (6.9) (21.3) (19.1) (14.1) (12.2) (5.4) (7.6)
Investing Activities
Capital Expenditure 0 0 0 (0.2) (0.1) (0.1) (0.3) (0.1) (0.0) (0.1) 0.1 (0.0) (0.0) (0.2) (0.1) (0.0) (0.0) (0.0) (0.6) (0.1) (0.7) (0.0) (0.0) (0.0)
Acquisitions 0 0 0 0 0 0 0 0 0 0 (25.9) 46.6 0 0 0 0 0 0 0 0 0 0 0 0
Purchases of Investments (19.9) (14.7) (48.9) (127.4) (31.4) (34.3) (163.5) (41.5) (87.6) (63.4) (34.1) (106.6) 0 (131.4) 0 0 0 0 (25.1) (40.0) 0 0 0 0
Sales/Maturities of Investments 61.5 42.5 75 88.5 80 63.5 67 61 75 55 60 60 45 20 0 0 0 0 0 0 0 0 0 0
Other Investing Activities 0 0 (2) (5.9) 0 0 (5) (2.5) 0 0 25.9 (46.6) 0 0 0 0 0 0 0 0 0 0 0 0
Investing Cash Flow 41.6 27.8 24.1 (45.0) 48.6 29.1 (101.8) 16.8 (12.6) (8.5) 26.0 (46.6) 45.0 (111.5) (0.1) (0.0) (0.0) (0.0) (25.7) (40.1) (0.7) (0.0) (0.0) (0.0)
Financing Activities
Net Debt Issuance 0 0 (0.7) 97.0 0 0 0 0 0 0 0 0 0 0 (6.0) (0.9) (0.9) (0.9) 0 0 (0.5) (0.3) (0.1) (0.3)
Stock Repurchased 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Dividends Paid 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Financing Activities 2.4 0.1 0.1 2.6 0 0 69.4 0 0 0 0 0 0 0 199.8 (0.6) 0 0 0 0 0 0 0 0
Financing Cash Flow 3.2 0.2 1.1 100.0 2.7 0.7 70.9 0.7 0.5 0.3 1.8 0.9 2.9 1.3 193.8 (1.6) (0.6) (0.9) 0.3 0.1 0.3 (0.1) 11.9 21.3
Cash Position
Net Change in Cash (16.2) (17.0) (18.2) 8.0 11.7 (11.0) 11.2 3.0 (19.4) (15.0) 10.4 (58.5) 31.2 (122.7) 173.2 (7.3) (15.3) (7.9) (46.6) (59.0) (14.5) (12.4) 0 (10.0)
Cash at Beginning 24.3 41.3 59.6 51.5 39.9 50.8 39.7 36.6 56.0 71.0 60.5 119.0 87.9 210.5 37.3 44.6 234.0 60.1 300.7 359.7 374.2 386.6 0 10.0
Cash at End 8.2 24.3 41.3 59.6 51.5 39.9 50.8 39.7 36.6 56.0 71.0 60.5 119.0 87.9 210.5 37.3 218.7 52.2 254.0 300.7 359.7 374.2 0 0
Free Cash Flow (60.9) (44.9) (43.5) (47.2) (39.6) (40.8) 41.7 (14.6) (7.3) (6.8) (17.3) (12.8) (16.7) (12.6) (20.6) (5.7) (7.0) (6.9) (21.9) (19.2) (14.8) (12.2) (5.4) (7.7)
Key Metrics 2026 Q2 2026 Q1 2025 Q4 2025 Q3 2025 Q2 2025 Q1 2024 Q4 2024 Q3 2024 Q2 2024 Q1 2023 Q4 2023 Q3 2023 Q2 2023 Q1 2022 Q4 2022 Q3 2022 Q2 2022 Q1 2021 Q4 2021 Q3 2021 Q2 2021 Q1 2020 Q4 2020 Q2 2020 Q1 2019 Q4
Income Statement
Revenue 33.7 22.7 28.1 32.5 15.7 8.0 86.6 2.1 0.5 0 0 0 0.0 0.0 0 0.2 0.5 0.7 0.8 0.5 2.1 2.1 0 0 0 0
Gross Profit 20.8 16.4 24.9 24.3 10.7 3.9 82.7 2.0 (6.4) (5.2) (3.4) (3.0) (7.2) (6.4) (3.6) (3.6) (3.9) (4.8) (3.2) (4.6) (3.5) (3.5) (0.5) (0.4) (0.4) (0.4)
Operating Income (61.5) (60.1) (41.5) (53.2) (47.6) (37.2) 47.2 (21.7) (15.3) (13.2) (10.2) (18.0) (20.6) (18.7) (15.4) (6.6) (6.3) (7.1) (5.0) (5.6) (4.4) (4.4) (13.1) (6.5) (5.2) (6.9)
Net Income (62.3) (60.6) (41.3) (51.2) (44.9) (33.9) 49.9 (19.1) (12.5) (10.3) (7.2) (14.9) (17.4) (15.0) (14.4) (6.6) (6.4) (7.2) (5.1) (5.8) (4.6) (4.6) (13.1) (6.5) (5.3) (7.0)
EPS (Diluted) -0.63 -0.61 -0.42 -0.52 -0.46 -0.35 0.51 -0.20 -0.13 -0.11 -0.07 -0.16 -0.18 -0.16 -0.15 -0.07 -0.07 -0.08 -0.15 -0.17 -0.13 -0.13 -0.38 -0.19 -0.16 -0.21
Balance Sheet
Cash & Equivalents 8.2 24.3 41.3 59.6 51.5 39.9 50.8 39.7 36.6 56.0 71.0 60.5 119.0 87.9 210.5 37.3 44.6 234.0 60.1 300.7 359.7 374.2 386.6 10.0
Total Assets 249.5 287.6 327.7 372.8 313.5 327.3 351.2 217.6 222.0 227.6 233.2 248.6 258.8 271.2 281.4 39.7 46.0 312.5 61.4 352.6 367.0 382.2 394.8 15.6
Total Debt 171.6 96.5 96.4 1.5 1.7 0.1 0.0 0.1 0.2 0.2 0.3 0.3 0.4 0.4 0.5 6.3 7.3 5.6 9.0 6.2 2.7 3.5 4.1 15.6
Stockholders' Equity 12.5 61.3 114.3 147.7 192.3 229.0 256.8 201.0 215.2 223.9 230.8 237.3 248.6 261.2 272.9 25.9 (44.0) 293.2 (31.3) 332.1 349.6 368.5 382.9 (5.6)
Cash Flow
Operating Cash Flow (60.9) (44.9) (43.5) (47.0) (39.6) (40.7) 42.0 (14.5) (7.3) (6.7) (17.4) (12.8) (16.7) (12.4) (20.5) (5.7) (7.0) (6.9) (21.3) (19.1) (14.1) (12.2) (5.4) (7.6)
Capital Expenditure 0 0 0 (0.2) (0.1) (0.1) (0.3) (0.1) (0.0) (0.1) 0.1 (0.0) (0.0) (0.2) (0.1) (0.0) (0.0) (0.0) (0.6) (0.1) (0.7) (0.0) (0.0) (0.0)
Free Cash Flow (60.9) (44.9) (43.5) (47.2) (39.6) (40.8) 41.7 (14.6) (7.3) (6.8) (17.3) (12.8) (16.7) (12.6) (20.6) (5.7) (7.0) (6.9) (21.9) (19.2) (14.8) (12.2) (5.4) (7.7)